Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of Motor Unit Potentials Duration as the Biomarker of DT-DEC01 Cell Therapy Efficacy in Duchenne Muscular Dystrophy Patients up to 12 Months After Systemic-Intraosseous Administration.
Niezgoda A, Biegański G, Wachowiak J, Czarnota J, Siemionow K, Heydemann A, Ziemiecka A, Sikorska MH, Bożyk K, Siemionow M. Niezgoda A, et al. Among authors: bieganski g. Arch Immunol Ther Exp (Warsz). 2023 Nov 24;71(1):24. doi: 10.1007/s00005-023-00691-y. Arch Immunol Ther Exp (Warsz). 2023. PMID: 37999748 Free PMC article.
Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First-in-Human Study with Minimum 6 Months Follow-up.
Heydemann A, Bieganski G, Wachowiak J, Czarnota J, Niezgoda A, Siemionow K, Ziemiecka A, Sikorska MH, Bozyk K, Tullius SG, Siemionow M. Heydemann A, et al. Among authors: bieganski g. Stem Cell Rev Rep. 2023 Jul;19(5):1340-1359. doi: 10.1007/s12015-023-10530-4. Epub 2023 Mar 31. Stem Cell Rev Rep. 2023. PMID: 37000376 Free PMC article.
Safety and Efficacy of DT-DEC01 Therapy in Duchenne Muscular Dystrophy Patients: A 12 - Month Follow-Up Study After Systemic Intraosseous Administration.
Siemionow M, Biegański G, Niezgoda A, Wachowiak J, Czarnota J, Siemionow K, Ziemiecka A, Sikorska MH, Bożyk K, Heydemann A. Siemionow M, et al. Among authors: bieganski g. Stem Cell Rev Rep. 2023 Nov;19(8):2724-2740. doi: 10.1007/s12015-023-10620-3. Epub 2023 Sep 14. Stem Cell Rev Rep. 2023. PMID: 37707670 Free PMC article.
Characteristics of Selected Somatic and Motor Abilities of Youth Soccer Players with Diabetes Type 1 Treated with Insulin Pump Therapy.
Krzykała M, Domaszewska K, Woźniewicz-Dobrzyńska M, Kryściak J, Konarska A, Araszkiewicz A, Zozulińska-Ziółkiewicz D, Gawrecki A, Biegański G, Konarski JM. Krzykała M, et al. Among authors: bieganski g. Int J Environ Res Public Health. 2021 Mar 27;18(7):3493. doi: 10.3390/ijerph18073493. Int J Environ Res Public Health. 2021. PMID: 33801780 Free PMC article.
Assessment of changes in blood lactate levels in children and adolescents with type 1 diabetes during a football tournament (GoalDiab Study).
Flotyńska J, Gawrecki A, Araszkiewicz A, Parchimowicz M, Michalski M, Różańska O, Stopczyńska-Szymecka M, Kamiński M, Cieluch A, Biegański G, Michalak A, Domaszewska K, Zozulińska-Ziółkiewicz D. Flotyńska J, et al. Among authors: bieganski g. Pediatr Endocrinol Diabetes Metab. 2021;27(4):237-244. doi: 10.5114/pedm.2021.109272. Pediatr Endocrinol Diabetes Metab. 2021. PMID: 35114764 Free PMC article.
Nighttime Hypoglycemia in Children with Type 1 Diabetes after one Day of Football Tournament.
Kamiński M, Gawrecki A, Araszkiewicz A, Szadkowska A, Skowrońska B, Stankiewicz W, Michalak A, Cieluch A, Dżygało K, Seget S, Biegański G, Adamska A, Ksiądz K, Szymańska-Garbacz E, Flotyńska J, Zozulinska-Ziolkiewicz D. Kamiński M, et al. Among authors: bieganski g. Int J Sports Med. 2020 Oct;41(13):972-980. doi: 10.1055/a-1192-5992. Epub 2020 Jul 7. Int J Sports Med. 2020. PMID: 32634846
Assessment of Safety and Glycemic Control During Football Tournament in Children and Adolescents With Type 1 Diabetes-Results of GoalDiab Study.
Gawrecki A, Araszkiewicz A, Szadkowska A, Biegański G, Konarski J, Domaszewska K, Michalak A, Skowrońska B, Adamska A, Naskręt D, Jarosz-Chobot P, Szypowska A, Klupa T, Zozulińska-Ziółkiewicz D. Gawrecki A, et al. Among authors: bieganski g. Pediatr Exerc Sci. 2019 Nov 1;31(4):401-407. doi: 10.1123/pes.2018-0264. Epub 2019 Jun 27. Pediatr Exerc Sci. 2019. PMID: 30955442
Transient lesion in the splenium of the corpus callosum due to rotavirus infection.
Mazur-Melewska K, Jonczyk-Potoczna K, Szpura K, Biegański G, Mania A, Kemnitz P, Służewski W, Figlerowicz M. Mazur-Melewska K, et al. Among authors: bieganski g. Childs Nerv Syst. 2015 Jun;31(6):997-1000. doi: 10.1007/s00381-015-2646-1. Epub 2015 Feb 17. Childs Nerv Syst. 2015. PMID: 25686898 Free PMC article.
[Effects of massage on delayed-onset muscle soreness].
Bakowski P, Musielak B, Sip P, Biegański G. Bakowski P, et al. Among authors: bieganski g. Chir Narzadow Ruchu Ortop Pol. 2008 Jul-Aug;73(4):261-5. Chir Narzadow Ruchu Ortop Pol. 2008. PMID: 18847018 Clinical Trial. Polish.
11 results